Financial Losses Financial Misrepresentation Fraudulent Schemes Financial Mismanagement Financial Misconduct Institutional Investors Fraudulent Investments Risk Management Stock Market Public Companies Financial Management Biopharmaceutical Companies Fund Performance Fundraising Fraud Allegations Securities Legal Actions Quarterly Reports Activist Investors Natural Persons Scams Corporate Communication Financial Health Capital Management Investor Communication Rental Income Misuse of Funds Stake Acquisition Materiality Market Regulation Business Acquisition Trust Building Market Communication Pressure Tactics Capital Raising Market Offers Regulatory Oversight Annual Reports Business Collapse Fraudulent Activities Fraudulent Practices Market Integrity Investment Risks Capital Markets Securities Fraud Market Impact Networking Market Strategies Investor Letters Market Trends Financial Statements Dividends Market Demand Investor Losses Financial Risk Analyst Disclosures Meeting with Trump Securities Offering Debt Recovery Market Transparency Returns Financial Obligations
The case stems from the company’s admission of pervasive accounting errors that triggered a near-40% one-day share drop.
